Santa Ana Bio Advances SAB01 Into Phase 1
ALAMEDA, Calif. — September 14, 2026 Santa Ana Bio announced that the first cohort has been dosed in the...
mast cells
Advertisement
Celldex Reports Phase 2 Barzolvolimab Results in Prurigo Nodularis
HAMPTON, N.J., July 21, 2026 Celldex announced topline results from its Phase 2 clinical trial evaluating barzolvolimab in patients...
Nurix Shows Promising CSU Data for Bexobrutideg
BRISBANE, Calif., May 14, 2026 Nurix Therapeutics presented new preclinical and Phase 1 translational data at the Society for...
Celldex Barzolvolimab Shows Strong Phase 2 Urticaria Data
Hampton, N.J., USA | March 27, 2026 Celldex Therapeutics reported compelling results from Phase 2 clinical trials of barzolvolimab,...
Advertisement
